Table 1.

Participant flow and primary and secondary outcomes: New York, NY, 2012–2015

	Three Seek-Test Approaches
	1 RDS-CTT (N=3005)	2 RDS-AST (N=484)	3 VBS (N=403)
				CTT vs. AST Risk Ratio 95% CI	CTT vs. AST p-value	CTT vs. VBS Risk Ratio 95% CI	CTT vs. VBS p-value	AST vs. VBS Risk Ratio 95% CI	AST vs. VBS p-value
Primary outcome
Confirmed newly diagnosed HIV-infection A	29 1.0%	14 4.0%	2 0.3%	0.26 (0.08–3.60)	0.06	3.84 (1.05–11.36)	0.03	14.89 (1.01–48.18)	<.01
Secondary outcomes
Screened for eligibility	5057	661	565
Found eligible B	3445 66.3%	525 79.1%	428 71.5%	0.84 (0.78–0.90)	<.01	0.93 (0.84–1.03)	0.17	1.11 (0.98–1.25)	0.09
Enrolled into the study and completed baseline interview C	3005 83.3%	484 87.4%	403 92.6%	0.95 (0.88–1.04)	0.26	0.90 (0.85–0.96)	<.01	0.94 (0.86–1.03)	0.20
Offered HIV testing D	2380 78.9%	484 100%	403 100%
Accepted HIV testing/tested E	2297 96.7%	477 97.8%	385 97.1%	0.99 (0.96–1.01)	0.36	1.00 (0.97–1.02)	0.70	1.01 (0.98–1.04)	0.60
Overall HIV prevalence (previously and newly diagnosed) F	140 7.4%	28 10.3%	2 0.3%	0.72 (0.39–1.84)	0.40	27.34 (10.36–75.86)	<.01	38.08 (10.77–112.20)	<.01

^A- Among tested

^B- Among screened

^C- Among eligible

^D- Among enrolled with baseline interview

^E- Among offered testing

^F- Among tested and previously diagnosed